跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Bilwin 20 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Bilwin 20
Approved
STANDARD
Bilwin 20
Stallion Laboratories Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
76d3c29d909dff69
Company
Stallion Laboratories Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
76d3c29d909dff69
Drug Approval Philippines Name
Bilwin 20
Product Name
Bilwin 20
Registration Number
DRP-14872
Brand Name
Bilwin 20
Generic Name
Bilastine
Dosage Form
Tablet
Dosage Strength
20 mg
Manufacturer
Stallion Laboratories Pvt. Ltd.
Importer
Ambica International Corporation
Distributor
Ambica International Corporation
Issuance Date
26 January 2024
Expiry Date
26 January 2029
Pharmacologic Category
Antihistamine
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
76d3c29d909dff69
Type
Standard
Back to Philippines FDA Approvals